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Purpose: To report the use of a new self-expanding endograft for percutaneous treatment
of iatrogenic subclavian artery perforations.
Case Reports: The subclavian artery of 2 patients was inadvertently cannulated during
percutaneous attempts to implant a permanent pacemaker in one and catheterize the sub-
clavian vein in the other. Because both patients had serious comorbidities, endovascular
repair of the subclavian perforations was performed using the Hemobahn endograft, a
nitinol stent covered internally with expanded polytetrafluoroethylene. The endoprosthe-
ses were successfully deployed via an ipsilateral brachial artery access. No signs of en-
dograft occlusion, migration, deformation, or fracture have been observed during follow-
up at 12 and 10 months, respectively, in these patients.
Conclusions: The Hemobahn stent-graft appears well suited to repairing subclavian artery
injuries. Longer follow-up will determine if the design of this endograft will resist com-
pression in this vascular location.
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The subclavian vein is readily accessible via
a supra- or infraclavicular approach, so it is
frequently used for central venous access,
central venous pressure monitoring, and pro-
longed parenteral nutrition.1,2 Transcutaneous
subclavian vein puncture and cannulation is
also the technique of choice for permanent
transvenous pacemaker implantation.3 We
describe 2 cases in which the subclavian ar-
tery (SA) was inadvertently cannulated during
attempted percutaneous catheterizations of
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the central venous circulation. The iatrogenic
complication was successfully managed by
endovascular treatment with a self-expanding
stent-graft.
CASE REPORTS
A 74-year-old severely obese woman with a
history of insulin-dependent diabetes and hy-
pertension presented to another hospital with
heart failure and Mobitz-II A-V block, alternat-
ing with complete A-V block. Several attempts
to implant a permanent pacemaker failed, and
a temporary pacemaker was positioned in the
apex of the right ventricle through the right
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femoral vein. The patient was transferred to
our institute, where physical examination on
admission showed cardiac failure with hypo-
tension (90/60 mm Hg) and reduced arterial
pO2 (78 mm Hg). Cardiomegaly was evident
on the chest radiograph.
Permanent pacemaker implantation was
planned, and a left percutaneous subclavian
vein approach was attempted with an 18-G
needle. Slow return of dark blood suggested
that the vein had been entered, so a guide-
wire and sheath were introduced for place-
ment of the pacing lead. However, radiogra-
phy disclosed the lead within the posterior
silhouette of the heart and a right bundle
branch block was evident on electrocardiog-
raphy, indicating that the lead had been intro-
duced in the left subclavian artery and posi-
tioned in the left ventricle. After consultation
with the cardiothoracic surgeon, the patient
was deemed at high risk for surgical interven-
tion, so an endovascular approach to seal the
perforation was elected.
The patient was pretreated with 5000 units
of heparin, 325 mg of aspirin, and prophylac-
tic antibiotics. A 7-F internal mammary artery
guide catheter was placed at the ostium of the
left SA via the right femoral artery. Angiog-
raphy showed the pacemaker lead entering
the left SA (Fig. 1A). A 30-MHz Ultracross 3.2-
F intravascular ultrasound (IVUS) catheter
(CVIS, Boston Scientific/SCIMED, Natick, MA
USA) was advanced over a 0.014-inch guide-
wire distal to the pacing lead insertion site.
IVUS imaging (Fig. 1B) with automatic pull-
back confirmed the intraluminal position of
the lead; measurements of the vessel diame-
ters proximal and distal to the lead entry were
recorded for stent-graft sizing.
To repair the injury, an 8-mm-wide, 10-cm-
long Hemobahn endograft (Figs. 1C,D) (W.L.
Gore & Associates, Flagstaff, AZ, USA) was
advanced over a 0.020-inch guidewire
through a 9-F introducer inserted into the sur-
gically exposed left brachial artery; the device
was positioned under fluoroscopic control in
the left SA and across the pacing lead entry
site. The lead was then withdrawn, and the
stent-graft was simultaneously deployed. An
8- 3 20-mm peripheral balloon catheter
(PowerFlex Plus, Cordis, Roden, The Nether-
lands) inflated to 8 atmospheres was used to
fully expand the stent-graft and optimize its
apposition to the arterial wall.
Completion angiography (Fig. 1E) and IVUS
imaging documented a satisfactory result
without contrast extravasation. The introduc-
er sheath was removed, and the brachial ar-
tery was repaired under local anesthesia. The
next day, permanent pacemaker implantation
was successfully performed through a surgi-
cal left cephalic vein approach. Endograft pa-
tency was demonstrated at 12 months by du-
plex ultrasonography; radiography of the left
subclavian artery showed no displacement,
deformation, or fracture of the stent-graft.
In the second case, an 83-year-old man suf-
fered a stroke while recovering from elective
coronary bypass surgery. Due to limited ve-
nous access, central venous catheterization
was necessary for patient monitoring and in-
fusion therapy. An attempt to cannulate the
right subclavian vein from the infraclavicular
approach resulted in placement of a 7-F, tri-
ple-lumen polyurethane CVP catheter in the
SA (Fig. 2A). Owing to the critical condition of
the patient, an endografting procedure was
planned to repair the SA. Twenty-four hours
later, an 8-mm-wide, 10-cm-long Hemobahn
stent-graft was placed into the right SA via
the surgically exposed right brachial artery
using the technique described above. Postin-
terventional angiography (Fig. 2B) and IVUS
imaging confirmed a satisfactory result. Nor-
mal arterial flow through the graft was doc-
umented by duplex scanning at the 10-month
follow-up examination. No migration, defor-
mation, or stent-graft fracture was seen on
fluoroscopic examination of the right SA.
DISCUSSION
Accidental puncture of the SA is a recognized
complication of percutaneous central venous
catheter placement via the subclavian
route.1,2 The mishap is usually easily recog-
nized by the pulsating bright red blood return
in the aspirating syringe. Usually no ill effect
will result if a small gauge needle is used and
promptly withdrawn without sideward mo-
tion. However, the accident is aggravated if
arterial puncture is not recognized and an in-
troducer is inserted. Catastrophic bleeding
can result when the sheath is withdrawn.2
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Figure 1l In the first patient, the preop-
erative angiogram (A) and the IVUS scan
(B) show the pacemaker lead (arrow) pen-
etrating the left subclavian artery. A He-
mobahn stent-graft (C) consists of a self-
expanding nitinol exoskeleton lined
internally by ultrathin expanded ePTFE
that is bonded to the stent by a nonporous
1-mm-wide tape along its entire length. (D)
The self-expanding Hemobahn is de-
ployed by pulling a fiber that releases the
knots along the endoprosthesis. (E) The
completion arteriogram shows the well-
positioned endograft with no evidence of
contrast extravasation or side branch ob-
struction.
As the cases described here illustrate, in-
advertent SA cannulation is often due to
predisposing factors. Arterial entry may be
entirely unrecognized because arterial desat-
uration makes the blood appear venous, or
because hypotension or diminished arterial
pulse pressure dampens pulsatile flow. Cen-
tral venous access with Doppler ultrasound-
guided needles has been proposed as an al-
ternative to blind puncture,4 which may be
particularly advantageous for patients in
whom difficult venous cannulation is antici-
pated.
When the subclavian artery has been inad-
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Figure 2lPreoperative angiogram (A) in the second patient showing a triple-lumen polyure-
thane CVP catheter (arrow) entering the right subclavian artery. After Hemobahn deployment,
the completion angiogram (B) documents arterial patency and precise endograft positioning
without endoleak or compromised subclavian branches.
vertently cannulated with large-caliber cathe-
ters, their immediate removal and application
of pressure at the entry site may not prevent
hematoma and potentially fatal hemorrhage.
Therefore, surgical closure of the perforation
under general anesthesia has been advocat-
ed, but surgical access is difficult in this lo-
cation, and the potential for exsanguinating
hemorrhage is ever present.5 Although supra-
and infraclavicular surgical exposures can be
used, a more aggressive operative approach
with median sternotomy, clavicular resection,
or thoracotomy may be needed to obtain wid-
er SA exposure and vascular control.6
Our patients were considered to be at ele-
vated surgical and anesthetic risk because of
their underlying medical conditions, so we
decided to manage the complications with
endovascular stent-grafts. Alternatively, we
could have used a vascular closure device to
seal the entry sites with the advantages of an
easier procedure, lower cost, and avoidance
of permanent implants. However, closure de-
vices have a less than 100% success rate, and
external manual compression is often re-
quired to achieve complete hemostasis, es-
pecially after collagen plug deployment. This
would have been difficult and ineffective giv-
en the intrathoracic location of the injury.7
Even percutaneous suture-mediated devices
require guidewire placement, which would
have been difficult in the presence of a pace-
maker lead.8
Endovascular repair of penetrating SA inju-
ries and hemorrhage is well documented,9,10
but so too are the cases of graft compression
and fracture in subclavian endografts.9,11,12 Ini-
tially, this complication was seen in devices
made with easily deformable, longitudinally
inflexible Palmaz stents,9 but self-expanding
stent-grafts have also failed in this location.11,12
The Hemobahn endoprosthesis, which fea-
tures a self-expanding nitinol stent covered in-
ternally with ultrathin expanded polytetrafluo-
roethylene, has been specifically designedfj
for percutaneous endovascular treatment of
peripheral arteries.13,14 The exoskeleton’s lon-
gitudinal flexibility and shape memory should
make this endograft resistant to deformation
by mechanical forces and vascular flexure. In
our 2 cases, the stent-grafts have remained
widely patent for 10 and 12 months. However,
more extensive, long-term clinical experience
is needed to confirm the durability of the He-
mobahn device at flexion or extrinsic com-
pression points.
Stent-graft failure in follow-up may be influ-
enced by other factors, such as thromboge-
nicity and tissue response. Incomplete en-
dothelialization of the graft may cause
thrombosis, while exuberant neointimal hy-
perplasia may compromise patency. Experi-
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mental studies have demonstrated that the
microstructure of the Hemobahn graft mate-
rial promotes rapid endothelialization of flow
surfaces, reducing the risk of thrombosis.15
However, there is no evidence that endothe-
lialization of ePTFE occurs in human vessels,
and clinical studies will be needed to confirm
these promising results.
Because the Hemobahn stent-graft auto-
matically expands to a predetermined diam-
eter when deployed, an important technical
component of successful implantation is care-
ful assessment of vessel diameter to select a
device of appropriate size. This can be per-
formed by angiography or, more accurately,
with IVUS imaging, which is also useful to
evaluate correct graft deployment. Usually, an
endoprosthesis with an unconstrained diam-
eter ;10% greater than the target vessel di-
ameter is sufficient to allow secure fixation
along the vascular segment.
The results obtained in our cases suggest
that endovascular repair may be successful in
the management of life-threatening subclavi-
an artery perforations complicating central
venous access, particularly in critically ill pa-
tients. However, longer follow-up will be nec-
essary to fully evaluate the safety and efficacy
of the Hemobahn device for this particular ap-
plication.
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